| [1] |
Bedossa P. Reversibility of hepatitis B virus cirrhosis after therapy: who and why?[J]. Liver Int, 2015, 35(1): 78-81. https://www.ncbi.nlm.nih.gov/pubmed/25529091
|
| [2] |
Puche JE, Saiman Y, Friedman SL. Hepatic stellate cells and liver fibrosis[J]. Compr Physiol, 2013, 3(4): 1473-92. https://www.ncbi.nlm.nih.gov/pubmed/17979495
|
| [3] |
Aykut UE, Akyuz U, Yesil A, et al. A comparison of FibroMeter (TM) NAFLD Score, NAFLD fibrosis score, and transient elastography as noninvasive diagnostic tools for hepatic fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease[J]. Scand J Gastroenterol, 2014, 49(11): 1343-8. https://www.ncbi.nlm.nih.gov/pubmed/25259621
|
| [4] |
Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease[J]. Hepatology, 2005, 41(6): 1313-21. doi: 10.1002/(ISSN)1527-3350
|
| [5] |
Foucher J, Castéra L, Bernard PH, et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations[J]. Eur J Gastroenterol Hepatol, 2006, 18(4): 411-2. doi: 10.1097/00042737-200604000-00015
|
| [6] |
Roulot D, Czernichow S, Le CH, et al. Beaugrand M.liver stiffness values in apparently healthy subjects:influence of gender and metabolic syndrome[J]. Hepatol, 2008, 48(5): 606-13. https://www.ncbi.nlm.nih.gov/pubmed/18222014
|
| [7] |
Salles N, Dussarat P, Foucher J, et al. Non-invasive evaluation of liver fibrosis by transient elastography and biochemical markers in elderly inpatients[J]. Gastroenterol Clin Biol, 2009, 33(4): 126-32. https://www.ncbi.nlm.nih.gov/pubmed/19193508
|
| [8] |
Ebinuma H, Saito H, Komuta M, et al. Evaluation of liver fibrosis by transient elastography using acoustic radiation force impulse: comparison with Fibroscan(R)[J]. J Gastroenterol, 2011, 46(10): 1238-48. doi: 10.1007/s00535-011-0437-3
|
| [9] |
Huwart L, Sempoux C, Salameh N, et al. Liver fibrosis:noninvasive assessment with Mr elastography versus aspartate aminotransferase-to-platelet ratio index[J]. Radiology, 2007, 245(2): 458-66. doi: 10.1148/radiol.2452061673
|
| [10] |
Kim BH, Lee JM, Lee YJ, et al. Mr elastography for noninvasive assessment of hepatic fibrosis: experience from a tertiary center in Asia[J]. J Magn Reson Imaging, 2011, 34(5): 1110-6. doi: 10.1002/jmri.22723
|
| [11] |
Godfrey EM, Patterson AJ, Priest AN, et al. A comparison of Mr elastography and P-31 Mr spectroscopy with histological staging of liver fibrosis[J]. Eur Radiol, 2012, 22(12): 2790-7. doi: 10.1007/s00330-012-2527-x
|
| [12] |
Castera L. Noninvasive methods to assess liver disease in patients with hepatitis B or C[J]. Gastroenterology, 2012, 142(6): 1293-302. doi: 10.1053/j.gastro.2012.02.017
|
| [13] |
Carlo F, Smirne C, Toniutto P, et al. Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: The role of AST to the platelet ratio index [J]. Clin Biochem, 2006, 39(4): 339-43. doi: 10.1016/j.clinbiochem.2006.01.011
|
| [14] |
Schiavon LL, Schiavon JL, Filho RJ, et al. Simple blood tests as noninvasive markers of liver fibrosis in hemodialysis patients with chronic hepatitis C virus infection[J]. Hepatology, 2007, 46(2): 307-14. doi: 10.1002/(ISSN)1527-3350
|
| [15] |
Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD[J]. Hepatology, 2007, 45(4): 846-54. doi: 10.1002/(ISSN)1527-3350
|
| [16] |
Musso G, Gambino R, Cassader M, et al. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity[J]. Ann Med, 2011, 43(8): 617-49. doi: 10.3109/07853890.2010.518623
|
| [17] |
Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology[J]. Gastroenterology, 2012, 142(7): 1592-609. doi: 10.1053/j.gastro.2012.04.001
|
| [18] |
Lichtinghagen R, Bahr MJ. Noninvasive diagnosis of fibrosis in chronic liver disease[J]. Expert Rev Mol Diagn, 2004, 4(5): 715-26. doi: 10.1586/14737159.4.5.715
|
| [19] |
Maor Y, Bashari D, Kenet G, et al. Non-invasive biomarkers of liver fibrosis in hemophilia patients with hepatitis C: Can you avoid liver biopsy[J]. Haemophilia, 2006, 130(4): 372-9. http://www.ncbi.nlm.nih.gov/pubmed/16834736
|
| [20] |
Lackner C, Struber G, Liegl B, et al. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C[J]. Hepatology, 2005, 41(6): 1376-82. doi: 10.1002/(ISSN)1527-3350
|
| [21] |
Myers RP, Ratziu V, Imbert-Bismut F, et al. Biochemical markers of liver fibrosis: A comparison with historical features in patients with chronic hepatitis C[J]. Am J Gastroenterol, 2002, 97(9): 2419-25. doi: 10.1111/j.1572-0241.2002.05997.x
|
| [22] |
Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C[J]. Gastroenterology, 2005, 128(2): 343-50. doi: 10.1053/j.gastro.2004.11.018
|
| [23] |
Patel K, Gordon SC, Jacobson I, et al. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients[J]. J Hepatol, 2004, 41(6): 935-42. doi: 10.1016/j.jhep.2004.08.008
|
| [24] |
Calès P, Oberti F, Michalak S, et al. A novel panel of blood markers to assess the degree of liver fibrosis[J]. Hepatology, 2005, 42(6): 1373-81. doi: 10.1002/(ISSN)1527-3350
|
| [25] |
Liu T, Wang X, Karsdal MA, et al. Molecular serum markers of liver fibrosis[J]. Biomark Insights, 2012, 7(1): 105-17. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412619/
|
点击查看大图
下载:
